Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia

被引：0
|
作者：
Juanjuan Zhao
Yongping Song
Delong Liu
机构：
[1] The first Affiliated Hospital of Zhengzhou University,Department of Oncology
[2] New York Medical College,Division of Hematology and Oncology
来源：
Biomarker Research | / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The original article [1] contains an error in the legend of Fig. 1 whereby it is incorrectly stated that MEC stands for ‘mitoprostate cancer using magnetic resonance imagingxantrone, etoposide, cyclophosphamide’. Correction to: Biomark Res (2019) 7:19. https://doi.org/10.1186/s40364-019-0170-2
引用
收藏
相关论文
共 50 条
  • [41] BPR1J271, a Novel FLT3 Inhibitor for Treating Acute Myeloid Leukemia
    Chen, C. T.
    Lin, W. H.
    Chou, L. H.
    Chen, C. P.
    Yen, S. C.
    Huang, Y. L.
    Yeh, T. K.
    Hsu, J. T. A.
    Jiaang, W. I.
    Chao, Y. S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 53 - 54
  • [42] Antitumor activity of the potent and novel FLT3 inhibitor HM43239 in acute myeloid leukemia
    Lee, Miyoung
    Ha, Young Eun
    Moon, Mi Jin
    Byun, Joo-Yun
    Yu, HyunKyung
    Kang, SeokJong
    Lee, Jaeho
    Lee, Kyuhang
    Kim, Eunkyung
    Kim, Eunyoung
    Lee, Ho Jeong
    Kim, YoungHoon
    Ahn, YoungGil
    Suh, KweeHyun
    Kim, Sun-Jin
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Novel targeted therapy for acute myeloid leukemia with a dual FLT3 and JAK2 inhibitor
    Yin-jun Lou
    Acta Pharmacologica Sinica, 2012, 33 : 212 - 213
  • [44] FLT3 Inhibitors for Treating Acute Myeloid Leukemia
    Hassanein, Mona
    Almahayni, Muhamad H.
    Ahmed, Syed O.
    Gaballa, Sameh
    El Fakih, Riad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (10): : 543 - 549
  • [45] Concurrent FLT3 Inhibitor and IDH Inhibitor Therapy in Patients with Acute Myeloid Leukemia (AML)
    Fathi, Amir T.
    Perl, Alexander E.
    Levis, Mark
    Smith, Catherine C.
    Brunner, Andrew M.
    Takahashi, Koichi
    Hock, Hanno R.
    Hobbs, Gabriela S.
    Narayan, Rupa
    Moran, Jenna A.
    Bergeron, Meghan
    Foster, Julia E.
    Daver, Naval
    DiNardo, Courtney D.
    BLOOD, 2020, 136
  • [46] FLT3 inhibitors for the treatment of acute myeloid leukemia
    Metzelder S.
    Röllig C.
    best practice onkologie, 2018, 13 (4) : 182 - 190
  • [47] Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature
    Arrigo, Giulia
    D'Ardia, Stefano
    Audisio, Ernesta
    Cerrano, Marco
    Freilone, Roberto
    Giai, Valentina
    Secreto, Carolina
    Urbino, Irene
    Frairia, Chiara
    ACTA HAEMATOLOGICA, 2022, 145 (05) : 566 - 570
  • [48] FLT3 Inhibitors in Acute Myeloid Leukemia: An Update
    Stone, R. M.
    ANNALS OF HEMATOLOGY, 2011, 90 : S70 - S72
  • [49] FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA IN CHILDHOOD
    Alonso, Cristina
    Rubio, Patricia
    Gallego, Marta
    Medina, Adriana
    Rossi, Jorge
    Felice, Maria
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 767 - 767
  • [50] Evaluation of a FLT3 Bite® for Acute Myeloid Leukemia
    Goldstein, Rebecca
    Henn, Anja
    Koppikar, Priya
    Archibeque, Ivonne
    Frank, Brendon
    Balazs, Mercedesz
    Dahlhoff, Christoph
    Raum, Tobias
    Li, Chi-Ming
    Wahl, Joachim
    Rock, Dan
    Thomas, Oliver
    Karbowski, Christine
    Krupka, Christina
    Subklewe, Marion
    Coxon, Angela
    Chapman-Arvedson, Tara
    BLOOD, 2017, 130
12345